Solid H1 performance

XP Power 25 July 2016 Update

XP Power

Solid H1 performance

Interim results

Tech hardware & equipment

25 July 2016

Price

1,599p

Market cap

£307m

$1.32:€1.20:£1

Net debt (£m) at end H116

6.0

Shares in issue

19.2m

Free float

85.6%

Code

XPP

Primary exchange

LSE

Secondary exchange

N/A

Share price performance

%

1m

3m

12m

Abs

(0.7)

(1)

(0.3)

Rel (local)

(6.3)

(6.1)

(0.4)

52-week high/low

1,733p

1,421p

Business description

XP Power is a developer and designer of power control solutions with production facilities in China, Vietnam and the US, and design, service and sales teams across Europe, the US and Asia.

Next events

Q3 trading update

7 October 2016

Analysts

Katherine Thompson

+44 (0)20 3077 5730

Dan Ridsdale

+44 (0)20 3077 5729

XP Power is a research client of Edison Investment Research Limited

XP reported revenue and order growth in H116, benefiting from the recent EMCO acquisition and the weakness in sterling. Despite Brexit uncertainty, the higher backlog supports management confidence in H216 growth. We have revised our forecasts to reflect the significantly weaker pound versus the dollar, resulting in EPS upgrades of 1.8% in FY16e and 2.6% in FY17e.

Year
end

Revenue (£m)

PBT*
(£m)

EPS*
(p)

DPS
(p)

P/E
(x)

Yield
(%)

12/14

101.1

24.3

101.1

61.0

15.8

3.8

12/15

109.7

25.7

104.3

66.0

15.3

4.1

12/16e

127.2

27.4

107.3

69.0

14.9

4.3

12/17e

136.4

30.5

119.5

73.0

13.4

4.6

Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.

H116: Revenue, order and profit growth

After a period of weaker demand from US customers in H215, XP saw good order growth in H116: +9% y-o-y/+14% h-o-h. Revenues grew 11.9% y-o-y (constant currency +7%), helped by the EMCO acquisition last November (£3.1m contribution in H116) and the weaker pound. Normalised operating profit of £13.2m grew 3.9% y-o-y, although the margin declined from 23.6% to 21.9% reflecting the recent investment in sales and engineering headcount and the lower profitability of EMCO. Net debt at the end of H116 increased to £6.0m from £3.7m at the end of FY15.

Outlook and changes to forecasts

Management expects to generate revenue growth in H216 as recent design wins move into production. The impact of the Brexit vote looks to be mixed for XP – the medium-term impact on customer demand is uncertain, but the weakness of sterling versus the dollar has a positive translational effect. Trade tariffs are unlikely to have a material impact due to XP’s Asian manufacturing base and overseas subsidiaries. We have factored in the lower sterling rate versus the US dollar; while this results in a small upgrade to our earnings forecasts (+1.8% in FY16e, +2.6% in FY17e), it has a negative effect on our reported working capital and net debt forecasts.

Valuation: Recent investment supports growth

While the economic outlook is mixed, we believe that XP should benefit from its recent investment in engineering and sales resource, as well as acquisitions in the US and South Korea. Strong forecast cash generation should enable the company to invest in further growth, either through internal product development or through the bolt-on acquisitions it continues to evaluate. XP now trades on a P/E of 14.9x FY16e and 13.4x FY17e normalised EPS, with a forecast dividend yield of 4.3% in FY16 and 4.6% in FY17. Competitor power converter companies are trading at around 21x FY16e EPS on EBITDA margins of c 16% versus XP’s 25% forecast EBITDA margin. The UK distributors are trading on c 17x FY16e EPS, on c 9% EBITDA margins. Based on XP’s superior margins, the company is undervalued versus peers, and is further supported by its dividend yield.

Review of H116 results

XP Power has reported H116 revenue growth of 11.9%; on a constant currency basis growth was 7%. The majority of this growth came from the EMCO acquisition, which contributed revenues of £3.1m in H116 (5.8% of reported growth). This implies Q216 revenues of £31.3m, +11% y-o-y and 8.1% q-o-q.

At £61.6m, H116 order intake was 9% higher than a year ago (+4% in constant currency), with EMCO contributing £4.0m of the total. Book-to-bill for H116 was 1.02x and backlog at the end of H116 was £50.0m, compared to £48.0m at the end of FY15.

Gross margin was negatively affected by the move in the euro versus the dollar in 2015. The rate moved from 1.371 in H114 to 1.116 in H115, staying at that level in H116. As most input costs are in dollars, for those customers invoiced in euros there would have been a big hit to profits in H115. The company countered this with a combination of putting up prices for euro-based invoices and having the benefit of a €/$ currency hedge. In H116, the higher prices were still in place, but there was no corresponding currency hedge, putting pressure on the margin compared to H115. As EMCO is a lower-margin business than XP, the EBITDA margin fell to 25.2% from 26.9% a year ago and 27.0% for FY15.

Net debt at the end of H116 rose to £6.0m, mainly as a result of US dollar strength versus sterling. At the end of H116, XP had gross term debt of $10.3m and a working capital facility of $7.5m, translated at a rate of $1.33/£ compared to $1.44/£ for the majority of the period before 23 June. Translation of dollar-denominated working capital also saw the same effect, resulting in a higher than expected working capital outflow.

Exhibit 1: Half-yearly results highlights

£m

H116

H115

y-o-y

Revenues

60.3

53.9

11.9%

Gross profit

29.5

26.6

10.9%

Gross margin

48.9%

49.4%

-0.4%

EBITDA

15.2

14.5

4.8%

EBITDA margin

25.2%

26.9%

-1.7%

Normalised operating profit

13.2

12.7

3.9%

Normalised operating margin

21.9%

23.6%

-1.7%

Reported operating profit

13.0

12.7

2.4%

Reported operating margin

21.6%

23.6%

-2.0%

Normalised PBT

13.1

12.6

4.0%

Normalised PAT

10.2

9.6

6.3%

Reported net income

9.8

9.6

2.1%

Normalised diluted EPS (p)

52.1

50.1

4.1%

Reported basic EPS (p)

51.6

50.5

2.0%

Net debt

6.0

0.4

1400.0%

Source: XP Power

Business update

Divisional revenues

The table below shows the H116 revenue split by end-market and geography. The healthcare business generated minimal growth y-o-y. Considering the strong dollar, this implies a small decline in underlying revenues. Management is confident that recent design wins moving into production will drive growth in the medium term. The technology business saw 11% growth y-o-y with stronger demand from semiconductor and broadcast customers. The industrials business saw the largest increase at 20% y-o-y, with a strong performance in Europe, a recovery in the US after a weak 2015 and a full six months’ contribution from EMCO. The majority of EMCO revenues are reported in the industrial segment, with small amounts in the healthcare and technology segments. Around half of EMCO’s revenues are generated in the US, with the next largest amount in Europe and the remainder in Asia.

Exhibit 2: Geographical revenue split by end-market (£m)

Healthcare

H115

H116

y-o-y

Industrial

H115

H116

y-o-y

Technology

H115

H116

y-o-y

North America

10.6

10.7

0.9%

North America

8.6

11.2

30.2%

North America

7.7

8.9

15.6%

Europe

6.0

6.0

0.0%

Europe

13.7

14.8

8.0%

Europe

3.5

3.8

8.6%

Asia

0.7

0.8

14.3%

Asia

1.7

2.8

64.7%

Asia

1.4

1.3

-7.1%

Total

17.3

17.5

1.2%

Total

24.0

28.8

20.0%

Total

12.6

14.0

11.1%

Source: XP Power

Manufacturing progress

The company continues to increase the level of power converter manufacturing in the Vietnam facility. The total number of converters produced across the China and Vietnam facilities was 550,000, of which 140,000 were made in Vietnam (25.5%). This compares to production in 2015, which split out as 590,000 in H115 (4.1% in Vietnam) and 810,000 in H215 (18.3% in Vietnam). The company continues to transfer products over to Vietnam, freeing up capacity in China for more complex products.

The level of own-design product increased by 20% to £43.4 (72% of total revenues) in H116 versus 67% in FY15. This was partly helped by the addition of EMCO, which is 100% own design.

Product development

The company accelerated new product introductions in H116 to 27 from 13 in H115 and 22 for FY15. This was partly due to the introduction of a new labelled product supplier for DC/DC converters. Of the 27 new products, 18 were “green”, ie high efficiency.

“Green” product revenues made up 24% of the H116 total compared to 21% in FY15, as customers seek out high-efficiency, high-reliability products.

Outlook and changes to forecasts

Outlook considering Brexit impact

Management is conscious of the uncertainty brought about by the Brexit vote, with the possibility that it could reduce customer demand, particularly in the UK. However, the weakness of sterling versus the dollar has a positive translational effect for XP as roughly three-quarters of revenues are invoiced in US dollars. In addition, the weak pound may increase the attractiveness of UK customers’ exports. In the UK (20% of sales), roughly two-thirds of sales are invoiced in sterling; the company is currently reviewing pricing for the sterling-based invoices.

As the majority of product is manufactured in Asia, it can be shipped to customers without passing through the UK, thereby avoiding any tariffs that may be put in place between the UK and the EU.

Although the capital goods markets remain subdued, the company expects to grow revenues in H216 as recent design wins move into production. Management also highlighted its strong balance sheet in the context of considering further acquisitions to widen its product offering and engineering capabilities.

Changes to forecasts

We have factored in the weaker sterling versus dollar rate (1.39 for FY16 and 1.35 for FY17). This has a positive impact at the revenue level, but as the company has a high level of natural hedging, the impact at the operating profit level is lower. We have factored in higher capex and a higher level of working capital, resulting in a higher net debt forecast at the end of FY16 and lower net cash at the end of FY17. Overall, we forecast a 1.8% increase in normalised EPS in FY16 and 2.6% in FY17.

Exhibit 3: Changes to estimates

£m

2016e

2017e

Old

New

Change

Old

New

Change

Revenues

122.2

127.2

4.0%

129.6

136.4

5.3%

Gross profit

61.1

62.6

2.4%

65.0

67.4

3.6%

Gross margin

50.0%

49.2%

-0.8%

50.2%

49.4%

-0.8%

EBITDA

31.2

32.0

2.3%

34.2

35.3

3.3%

EBITDA margin

25.6%

25.1%

-1.6%

26.4%

25.9%

-1.9%

Normalised operating profit

27.2

27.7

1.6%

30.1

30.8

2.4%

Normalised operating profit margin

22.3%

21.8%

-0.5%

23.2%

22.6%

-0.6%

Reported operating profit

27.2

27.4

0.5%

30.1

30.6

1.8%

Reported operating margin

22.3%

21.5%

-0.8%

23.2%

22.4%

-0.8%

Normalised PBT

27.0

27.4

1.4%

29.8

30.5

2.3%

Reported PBT

27.0

27.1

0.3%

29.8

30.3

1.6%

Normalised net income

20.2

20.6

1.8%

22.4

22.9

2.6%

Reported net income

20.2

20.3

0.3%

22.4

22.7

1.7%

Normalised basic EPS

106.5

108.4

1.8%

117.78

120.8

2.6%

Normalised diluted EPS

105.3

107.3

1.8%

116.56

119.5

2.6%

Reported basic EPS

106.5

106.8

0.3%

117.78

119.7

1.7%

Dividend per share

69.0

69.0

0.0%

73.0

73.0

0.0%

Net debt/(cash)

(1.8)

2.1

-220.0%

(8.1)

(3.9)

-52.1%

Source: Edison Investment Research

Exhibit 4: Financial summary

£m

2012

2013

2014

2015

2016e

2017e

31-December

IFRS

IFRS

IFRS

IFRS

IFRS

IFRS

INCOME STATEMENT

Revenue

 

 

93.9

101.1

101.1

109.7

127.2

136.4

Cost of Sales

(49.0)

(51.5)

(51.0)

(55.1)

(64.5)

(69.1)

Gross Profit

44.9

49.6

50.1

54.6

62.6

67.4

EBITDA

 

 

23.3

26.0

27.6

29.7

32.0

35.3

Normalised operating profit

 

 

21.0

23.3

24.5

25.9

27.7

30.8

Amortisation of acquired intangibles

0.0

0.0

0.0

0.0

(0.2)

(0.2)

Exceptionals

0.0

0.0

0.0

(0.3)

(0.1)

0.0

Share-based payments

0.0

0.0

0.0

0.0

0.0

0.0

Reported operating profit

21.0

23.3

24.5

25.6

27.4

30.6

Net Interest

(0.8)

(0.4)

(0.2)

(0.2)

(0.3)

(0.3)

Joint ventures & associates (post tax)

0.0

0.0

0.0

0.0

0.0

0.0

Exceptional & other financial

0.0

0.0

0.0

0.0

0.0

0.0

Profit Before Tax (norm)

 

 

20.2

22.9

24.3

25.7

27.4

30.5

Profit Before Tax (reported)

 

 

20.2

22.9

24.3

25.4

27.1

30.3

Reported tax

(4.5)

(4.5)

(4.8)

(5.5)

(6.5)

(7.3)

Profit After Tax (norm)

15.7

18.4

19.5

20.2

20.9

23.2

Profit After Tax (reported)

15.7

18.4

19.5

19.9

20.6

23.0

Minority interests

(0.2)

(0.2)

(0.1)

(0.2)

(0.3)

(0.3)

Discontinued operations

0.0

0.0

0.0

0.0

0.0

0.0

Net income (normalised)

15.5

18.2

19.4

20.0

20.6

22.9

Net income (reported)

15.5

18.2

19.4

19.7

20.3

22.7

Basic average number of shares outstanding (m)

19

19

19

19

19

19

EPS - basic normalised (p)

 

 

81.67

95.84

102.12

105.28

108.39

120.80

EPS - diluted normalised (p)

 

 

81.35

95.05

101.07

104.32

107.26

119.54

EPS - basic reported (p)

 

 

81.67

95.84

102.12

103.70

106.81

119.74

Dividend (p)

50

55

61

66

69

73

Revenue growth (%)

(9.4)

7.7

0.0

8.5

15.9

7.3

Gross Margin (%)

47.8

49.1

49.6

49.8

49.2

49.4

EBITDA Margin (%)

24.8

25.7

27.3

27.0

25.1

25.9

Normalised Operating Margin

22.4

23.0

24.2

23.6

21.8

22.6

BALANCE SHEET

Fixed Assets

 

 

52.8

53.3

56.1

65.4

66.9

67.7

Intangible Assets

38.1

39.1

40.5

48.2

49.4

50.5

Tangible Assets

13.2

12.7

14.4

16.1

16.4

16.1

Investments & other

1.5

1.5

1.2

1.1

1.1

1.1

Current Assets

 

 

39.3

42.2

47.0

53.5

58.4

63.1

Stocks

19.8

20.4

25.2

28.7

32.7

35.0

Debtors

14.2

15.4

16.0

17.5

20.2

21.7

Cash & cash equivalents

4.1

5.0

3.8

4.9

3.1

4.0

Other

1.2

1.4

2.0

2.4

2.4

2.4

Current Liabilities

 

 

(20.2)

(22.4)

(18.6)

(19.8)

(23.3)

(19.5)

Creditors

(11.1)

(12.7)

(14.4)

(14.6)

(16.9)

(18.2)

Tax and social security

(1.6)

(1.1)

(1.7)

(1.2)

(1.2)

(1.2)

Short term borrowings

(7.3)

(8.5)

(2.5)

(4.0)

(5.2)

(0.1)

Other

(0.2)

(0.1)

0.0

0.0

0.0

0.0

Long Term Liabilities

 

 

(10.6)

(3.7)

(4.2)

(10.0)

(5.4)

(5.4)

Long term borrowings

(7.4)

0.0

0.0

(4.6)

0.0

0.0

Other long term liabilities

(3.2)

(3.7)

(4.2)

(5.4)

(5.4)

(5.4)

Net Assets

 

 

61.3

69.4

80.3

89.1

96.5

105.9

Minority interests

(0.2)

(0.2)

(0.1)

(0.8)

(0.9)

(1.0)

Shareholders' equity

 

 

61.1

69.2

80.2

88.3

95.6

104.9

CASH FLOW

Op Cash Flow before WC and tax

23.3

26.0

27.6

29.7

32.0

35.3

Working capital

4.2

(0.3)

(4.1)

(4.6)

(4.4)

(2.5)

Exceptional & other

0.4

(0.5)

1.9

0.6

(0.1)

0.0

Tax

(4.3)

(5.0)

(3.6)

(4.7)

(6.5)

(7.3)

Net operating cash flow

 

 

23.6

20.2

21.8

21.0

21.0

25.5

Capex

(4.7)

(3.2)

(5.8)

(5.4)

(6.0)

(5.5)

Acquisitions/disposals

(1.6)

0.1

0.1

(8.3)

0.0

0.0

Net interest

(0.5)

(0.3)

(0.1)

(0.1)

(0.3)

(0.3)

Equity financing

(0.5)

0.1

(0.2)

0.0

0.0

0.0

Dividends

(9.1)

(10.1)

(11.0)

(12.2)

(13.1)

(13.7)

Other

0.5

0.2

0.1

0.2

0.0

0.0

Net Cash Flow

7.7

7.0

4.9

(4.8)

1.6

6.0

Opening net debt/(cash)

 

 

18.6

10.6

3.5

(1.3)

3.7

2.1

FX

0.3

0.1

(0.1)

(0.2)

0.0

0.0

Other non-cash movements

0.0

0.0

0.0

0.1

0.0

0.0

Closing net debt/(cash)

 

 

10.6

3.5

(1.3)

3.7

2.1

(3.9)

Source: Company accounts, Edison Investment Research

Edison, the investment intelligence firm, is the future of investor interaction with corporates. Our team of over 100 analysts and investment professionals work with leading companies, fund managers and investment banks worldwide to support their capital markets activity. We provide services to more than 400 retained corporate and investor clients from our offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2016 Edison Investment Research Limited. All rights reserved. This report has been commissioned by XP Power and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.
Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2016. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 9258 1161

Level 25, Aurora Place

88 Phillip St, Sydney

NSW 2000, Australia

Wellington +64 (0)48 948 555

Level 15, 171 Featherston St

Wellington 6011

New Zealand

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 9258 1161

Level 25, Aurora Place

88 Phillip St, Sydney

NSW 2000, Australia

Wellington +64 (0)48 948 555

Level 15, 171 Featherston St

Wellington 6011

New Zealand

Share this with friends and colleagues

You may be interested in